Healthcare -
Biotechnology - NASDAQ - US
$ 1.5049
13.2 %
$ 106 M
Market Cap
-2.25
P/E
SLS - SHORT-TERM DEBT
Short-term Debt SLS - SELLAS Life Sciences Group, Inc.
446 K
LAST VALUE
6.13%
2 YEAR CAGR
0.00%
5 YEAR CAGR
-14.60%
10 YEAR CAGR